Aids/Hiv Problem
8
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis
Resilience-based Psychosocial Intervention Among Children Affected by HIV/AIDS
N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV
Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients
Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection
Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in Lesotho